# Botulinum Toxin Injections for Oral Neuropathic Pain

> **NCT03555916** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 43 (actual)

## Conditions studied

- Trigeminal Neuropathy, Traumatic

## Interventions

- **DRUG:** BOTOX®, Allergan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03555916
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-04
- **Primary completion:** 2022-07-19
- **Final completion:** 2022-11-08
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2023-04-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03555916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03555916, "Botulinum Toxin Injections for Oral Neuropathic Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03555916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*